Apr 01, 2019

Clininvent gets USFDA Approval

Supported by a strong talent pool of over 800 qualified scientists of TCG Lifesciences (TCGLS), Clininvent Research Pvt. Ltd., the 100 percent subsidiary of TCGLS, has successfully passed a pre-approval inspection as a manufacturing plant, by the US Food and Drug Administration (USFDA). The inspection confirmed the site to be compliant with the principles and guidelines of Good Manufacturing Practices (GMP).